When a novel coronavirus struck in early 2020, Pfizer’sPFE-0.74%decrease; red down pointing triangle chief executive, Dr. Albert Bourla, saw an opportunity to help save the world. He pushed the ...
Pfizer offers a generous 5.73% dividend yield. The stock is trading at an attractive forward P/E of 9.5x 2026 earnings. The company has multiple potential growth drivers in its pipeline. Pfizer's ...
Few companies embody the term 'pharma giant' as much as Pfizer. Here we take a look at the colourful history of one of the biggest drugmakers in the world. Pfizer was founded in 1849 by two recent ...
Albert Bourla, who four years ago led Pfizer through its scientific and financial triumph during the covid-19 pandemic, is suddenly facing a new challenge from a large shareholder frustrated over ...
Pfizer taps Triana to discover molecular glues for cancer and beyond in deal potentially worth $1.5B
Big Pharma is sticking to the recent molecular glue investment trend, with Pfizer now the latest major drugmaker to get in on the action. Pfizer is laying out $49 million upfront in a partnership ...
Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pfizer has earned a nod from the U.S. regulator for another of its products in the indication. On Friday, the FDA signed ...
Pfizer's COVID-19 products continue to generate significant cash flow that helps bolster the company's dividend. The big drugmaker has opportunities to monetize assets to raise additional cash ...
LONDON, Oct 7 (Reuters) - Pfizer (PFE.N), opens new tab on Monday won a bid in a London court to invalidate two of GSK's (GSK.L), opens new tab patents relating to a respiratory syncytial virus ...
Oct 10 (Reuters) - The corporate clash between Pfizer (PFE.N), opens new tab and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate ...
Are you a print subscriber? Activate your account. By Tim Nudd - 1 hour 14 min ago By Adrianne Pasquarelli - 5 hours 42 min ago By Erika Wheless - 5 hours 42 min ago By Brian Bonilla - 5 hours 42 ...
The brewing proxy fight between activist Starboard Value and pharmaceutical giant Pfizer has already taken a hostile turn. Anonymous sources have been disparagingly suggesting that Pfizer CEO Dr ...
2024--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZIâ„¢ (marstacimab-hncq) for routine prophylaxis to prevent or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback